Scientists test heart drug for clues to prevent Alzheimer's
NCT ID NCT05386914
Summary
This study is investigating whether a short course of an FDA-approved drug called sirolimus can improve blood flow to the brain and lungs. It involves healthy adults, some with a genetic risk for Alzheimer's disease, to see how their bodies respond. Researchers are using advanced MRI scans to measure changes in blood flow before and after taking the drug, aiming to understand its potential effects on brain health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Missouri-Columbia
Columbia, Missouri, 65212, United States
Conditions
Explore the condition pages connected to this study.